Nuzenio

Opus Genetics Completes

Opus Genetics Completes news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 17 latest news signals 11 publisher sources 100/100 entity strength

Latest news

Is Opus Genetics Inc (IRD) Significantly Overvalued After Q2 Ear - GuruFocusGuruFocus · Sat, 08 Aug 2026 08:48:49 GMT EyeWorld Weekly, August 7, 2026 - EyeWorldEyeWorld · Fri, 07 Aug 2026 16:04:01 GMT Opus Genetics (NASDAQ: IRD) sets $300M shelf and $125M ATM stock plan - Stock TitanStock Titan · Fri, 07 Aug 2026 10:57:57 GMT Opus Genetics Reports Q2 2026 Results and Advances Multiple IRD Gene Therapy Programs with OPGx-BEST1 Data Expected in September - Quiver QuantitativeQuiver Quantitative · Thu, 06 Aug 2026 11:15:00 GMT Opus Genetics Announces Financial Results for Second Quarter 2026 and Provides Corporate Update - GlobeNewswireGlobeNewswire · Thu, 06 Aug 2026 11:00:00 GMT Vision gene-therapy data from Opus Genetics expected in September - Stock TitanStock Titan · Thu, 06 Aug 2026 11:00:00 GMT Opus Genetics Completes Phase 3 Enrollment for AAV Gene Therapy OPGx-LCA5 - BioPharm InternationalBioPharm International · Wed, 05 Aug 2026 19:39:16 GMT Opus Genetics Completes Enrollment in Phase 3 Trial of Gene Therapy for Inherited Retinal Disease - Eyewire+Eyewire+ · Tue, 04 Aug 2026 13:06:40 GMT

Timeline

Sat, 08 Aug 2026 08:48:49 GMTIs Opus Genetics Inc (IRD) Significantly Overvalued After Q2 Ear - GuruFocus

Fri, 07 Aug 2026 16:04:01 GMTEyeWorld Weekly, August 7, 2026 - EyeWorld

Fri, 07 Aug 2026 10:57:57 GMTOpus Genetics (NASDAQ: IRD) sets $300M shelf and $125M ATM stock plan - Stock Titan

Thu, 06 Aug 2026 11:15:00 GMTOpus Genetics Reports Q2 2026 Results and Advances Multiple IRD Gene Therapy Programs with OPGx-BEST1 Data Expected in September - Quiver Quantitative

Thu, 06 Aug 2026 11:00:00 GMTOpus Genetics Announces Financial Results for Second Quarter 2026 and Provides Corporate Update - GlobeNewswire

Thu, 06 Aug 2026 11:00:00 GMTVision gene-therapy data from Opus Genetics expected in September - Stock Titan

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.

Connected entities

OPGx12 live mentions IRD10 live mentions Enrollment9 live mentions Trial9 live mentions Opus Genetics8 live mentions Phase7 live mentions Associated Inherited Retinal6 live mentions RSU6 live mentions Inc5 live mentions Stock Titan Opus5 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Opus Genetics Completes.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

11 distinct publisher/source names are currently connected to this entity page.